BREAST CARCINOMA IN SITU
Clinical trials for BREAST CARCINOMA IN SITU explained in plain language.
Never miss a new study
Get alerted when new BREAST CARCINOMA IN SITU trials appear
Sign up with your email to follow new studies for BREAST CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo may help women with early breast cancer avoid mastectomy
Disease control ENROLLING_BY_INVITATIONThis study tests whether giving two drugs (trastuzumab and a taxane) before surgery can shrink HER2-positive breast cancer that hasn't spread, so more women can have breast-conserving surgery instead of mastectomy. About 54 women aged 18-70 with tumors at least 2 cm will receive …
Matched conditions: BREAST CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated May 26, 2026 03:20 UTC
-
Could a gel help fight breast cancer? new trial tests endoxifen
Disease control OngoingThis early-phase trial is testing a gel form of the drug endoxifen on the breast skin of 32 women scheduled for mastectomy. The goal is to find the safest dose and see how much drug gets into breast tissue. The study compares the gel to a placebo to understand side effects and po…
Matched conditions: BREAST CARCINOMA IN SITU
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Immunotherapy after chemo shows promise for aggressive breast cancer
Disease control OngoingThis phase 3 trial tests whether adding the immunotherapy drug pembrolizumab after standard chemotherapy helps prevent triple-negative breast cancer from returning. About 1,155 patients with residual cancer after chemo are randomly assigned to receive pembrolizumab or a placebo. …
Matched conditions: BREAST CARCINOMA IN SITU
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:56 UTC